Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Assets: 2010-2024

Historic Current Assets for Sunshine Biopharma (SBFM) over the last 12 years, with Dec 2024 value amounting to $26.0 million.

  • Sunshine Biopharma's Current Assets rose 7.64% to $28.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year increase of 7.64%. This contributed to the annual value of $26.0 million for FY2024, which is 4.32% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Current Assets of $26.0 million as of FY2024, which was up 4.32% from $24.9 million recorded in FY2023.
  • Sunshine Biopharma's 5-year Current Assets high stood at $27.3 million for FY2022, and its period low was $1.0 million during FY2020.
  • For the 3-year period, Sunshine Biopharma's Current Assets averaged around $26.1 million, with its median value being $26.0 million (2024).
  • Its Current Assets has fluctuated over the past 5 years, first soared by 1,461.89% in 2020, then declined by 8.87% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Current Assets (Yearly) stood at $1.0 million in 2020, then skyrocketed by 114.03% to $2.2 million in 2021, then spiked by 1,143.83% to $27.3 million in 2022, then dropped by 8.87% to $24.9 million in 2023, then climbed by 4.32% to $26.0 million in 2024.